Clinical trials
Biliary Atresia clinical trials
Below are recruiting biliary atresia clinical trials, each written for real people, not researchers. We’re tracking 18 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04272515Recruiting
Learn from tissue or samples from biliary atresia patients
This study looks to better understand biliary atresia by studying patient information and/or samples. It may help researchers learn why the condition happens and how to improve care.
Paris, DeAges Any age - NCT03273049Recruiting
Study of disease processes in children getting liver transplants
This study maps how biliary atresia (a childhood blockage/problem with bile flow from the liver) progresses and changes in the body around the time of a liver transplant. It may help doctors better understand the disease and improve future care.
Pittsburgh, PennsylvaniaAges Any age - NCT05072626Recruiting
Special fat formula for babies after biliary atresia surgery
This trial tests whether a special nutritional support formula rich in medium-chain fats can help infants with biliary atresia after the Kasai procedure. It may support feeding and liver recovery during the early months after surgery.
Shanghai, Shanghai MunicipalityAges Up to 3 months - NCT05848310Recruiting
Blood test before surgery to predict biliary atresia outcome
This study looks at a specific pre-surgery blood marker called FGF19 (and related liver blood tests) in children with biliary atresia. The goal is to see whether the blood results before surgery can help predict how well children recover after surgery.
Shanghai, Shanghai MunicipalityAges Any age - NCT07513038RecruitingPhase 1/Phase 2
Using dye imaging to diagnose bile duct blockage in infants
This trial tests whether a special fluorescent dye called indocyanine green (ICG) can help doctors better diagnose biliary atresia—a rare condition where a baby's bile ducts don't form properly. The dye is used during an imaging scan to light up the bile system so doctors can see it more clearly.
Boston, MassachusettsAges birth–3 months - NCT05426733Enrolling by invitationPhase 3
Long-term extension study of odevixibat for biliary atresia
This study follows children with biliary atresia who finished an earlier 104-week treatment study, to check how well odevixibat works over the long term and whether it remains safe. If you completed the prior study, this extension may be an option to continue monitoring and treatment.
Aurora, ColoradoAges Any age - NCT06564740Recruiting
Stem cell therapy for infants with biliary atresia and cirrhosis
This study is testing whether stem cells can help infants with liver cirrhosis from biliary atresia (a blocked bile duct condition) who have already had Kasai surgery. It aims to see if stem cell therapy can improve liver function and reduce complications.
Istanbul, IstanbulAges 2 months–18 years - NCT07709702Recruiting
Enhanced recovery after surgery for children with bile duct issues
This trial tests an enhanced recovery program (ERAS) to help children heal faster after surgery for two bile duct conditions: choledochal cyst and biliary atresia. The program includes steps to improve recovery, like better pain control and early eating.
Lahore, Punjab ProvinceAges 1 month–14 years - NCT06764082Recruiting
Nutrition study for babies with biliary atresia
This study tests whether a special nutrition plan helps babies with biliary atresia recover better after Kasai surgery. It is for infants under 3 months old who are ready for surgery.
Wuhan, HubeiAges 1 day–3 months - NCT06708572Recruiting
GCSF after Kasai surgery for biliary atresia
This study tests a medicine called GCSF (helps make white blood cells) in babies who have had Kasai surgery for biliary atresia. It aims to see if GCSF can improve liver function and overall outcomes.
Cairo, Menofia GovernorateAges 3 weeks–1 year - NCT00345553Recruiting
Study for children with biliary atresia
This study enrolls children and young adults with biliary atresia (a condition where bile can’t flow properly from the liver) to learn from their care and outcomes over scheduled visits. It may help researchers understand the disease better and improve future treatment.
Los Angeles, CaliforniaAges 6 months–20 years - NCT02137668RecruitingPhase 1
Testing vancomycin for certain pediatric bile duct conditions
This early-phase study tests whether the antibiotic vancomycin can help children with primary sclerosing cholangitis or biliary atresia, and related gut/bile duct problems. It may work by changing gut bacteria, but you would need to avoid certain medicines beforehand.
Sacramento, CaliforniaAges 2 weeks–40 years - NCT05399745Recruiting
Study of biliary atresia in children with heart disease
This trial is studying children who have biliary atresia, a serious liver problem, including some who also have tetralogy of Fallot (a congenital heart condition). It also includes healthy children for comparison, and may help researchers understand the illness and treatments better.
CopenhagenAges birth–18 years - NCT07697872Recruiting
The Dirty Nappy Study for babies with liver problems
This study looks at babies with possible liver problems (cholestasis) who have been referred to the Birmingham Liver Unit. Researchers want to collect information from nappy (diaper) samples to better understand these conditions.
BirminghamAges Up to 11 years - NCT05925309Recruiting
Oral antibiotics to prevent bile duct inflammation after Kasai surgery
This trial studies whether giving oral antibiotics before symptoms start can lower the chance of cholangitis (bile duct infection/inflammation) after Kasai portoenterostomy. It may help protect your child’s bile flow and reduce painful or serious infections after surgery.
Shanghai, Shanghai MunicipalityAges 2 weeks–3 months - NCT07250854RecruitingEarly Phase 1
Using a dye to help diagnose blocked bile ducts in newborns
This study tests if a special dye (ICG) and a camera can help doctors see blocked bile ducts in newborns with jaundice, so they can diagnose biliary atresia faster and without extra procedures.
Birmingham, AlabamaAges 2 weeks–4 months - NCT00061828Recruiting
Tracking Liver Disease in Newborns and Young Infants
This study follows babies under 6 months old who have early signs of liver disease (cholestasis) to better understand what causes it and how it progresses. Researchers will collect medical information over time to improve diagnosis and treatment.
Los Angeles, CaliforniaAges Up to 6 months - NCT01793168Recruiting
Rare disease registry and history study
This study keeps a registry (a structured list) of people with rare diseases and may also track how the condition changes over time. It can help researchers better understand rare illnesses and find gaps in care, which may improve future treatments.
Sioux Falls, South DakotaAges Any age
Hear when a new Biliary Atresia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Biliary Atresia trials by city
Studies with a site in or near these metro areas.
Biliary Atresia trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for biliary atresia?
- Yes. Clin2 currently lists 18 recruiting biliary atresia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a biliary atresia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a biliary atresia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.